The acquisition marks a significant step forward for Abu Dhabi state investor in the life sciences sector, positioning the UAE as a key player in the global market
KELIX bio, founded in November 2020, has swiftly emerged as a key player in the pharmaceutical industry, offering more products to markets across the Middle East, Africa and Asia